Table 5.
Breast AdCC |
Salivary AdCC |
Metastatic AdCC |
||||
---|---|---|---|---|---|---|
Percentage (%) | Mean intensity (range) | Percentage (%) | Mean intensity (range) | Percentage (%) | Mean intensity (range) | |
SOX10 | 93 (63-100) | 2.23 (1-3) | 83 (19-100) | 2.14 (1-3) | 96 (75-100) | 2.50 (2-3) |
c-KIT | 68 (25-100) | 2.19 (1-3) | 61 (13-100) | 1.94 (1-3) | 50 (15-87) | 1.67 (1-2) |
β-catenin | 100 (100) | 2.72 (2-3) | 94 (30-100) | 2.41 (1-3) | 100 (100) | 2.50 (2-3) |
EMA | 3 (0-17) | 0.72 (1-3) | 12 (1-52) | 1.49 (1-3) | 34 (1-93) | 2.00 (1-3) |
P63 | 56 (2-88) | 2.55 (2-3) | 64 (1-97) | 2.43 (1-3) | 50 (2-77) | 1.83 (1-3) |
CK7 | 73 (15-100) | 2.45 (1-3) | 82 (6-100) | 2.67 (2-3) | 81 (25-100) | 3.00 (3) |
CK5/6 | 66 (0-100) | 2.29 (1-3) | 79 (50-100) | 2.43 (1-3) | 50 (5-65) | 2.25 (1-3) |
Ki-67 | 7 (1-20) | N/A | 6 (1-27) | N/A | 12 (5-25) | N/A |
ARa | 1.9 (0-5) | 1.17 (0-3) | 2.02 (0-5) | 0.84 (0-2) | 1.58 (0-5) | 0.58 (0-2) |
Abbreviation: AdCC, adenoid cystic carcinoma.
AR is interpreted using the Allred scoring system (proportion score: 0-5; intensity score 0-3).